Johnson & Johnson engages in the manufacture and sale of various products in the health care field worldwide.
There is no perfect dividend growth stock, but JNJ comes close. The company enjoys a diverse revenue base, an excellent research pipeline, a pristine balance sheet and exceptional free cash-flows to cover it dividend. This diversity and strength will help the company overcome near-term results from patent losses on Risperdal and Topamax. I will continue to add to my position as my allocation allows and when JNJ is trading below my buy price of $70.24.
Source: Dividends Value
Related Articles:
Dividend Growth Stocks News
- 3 No-Brainer Dividend Stocks to Buy With $1,000 Right Now - The Motley Fool - 5/31/2025
- 3 Dividend Stocks to Buy With $500 and Hold Forever - The Motley Fool - 5/31/2025
- Should I buy these FTSE 100 dividend stocks with 8%+ yields before it’s too late? - Yahoo - 5/31/2025
- My Forever Portfolio: 5 Spectacular Dividend Stocks You Can Buy Now and Hold Forever - Nasdaq - 5/29/2025
- 2 High-Yield Canadian Dividend Stocks for Income Investors - Yahoo - 5/31/2025
- Genuine Parts Company (GPC) Dividend Stock Analysis - 5/30/2025
- AFLAC Incorporated (AFL) Dividend Stock Analysis - 5/23/2025
- Automatic Data Processing Inc. (ADP) Dividend Stock Analysis - 5/16/2025
- Air Products and Chemicals Inc. (APD) Dividend Stock Analysis - 5/9/2025
- Waste Management, Inc. (WM) Dividend Stock Analysis - 5/2/2025
Stock Analysis: Johnson & Johnson (JNJ)
Posted by D4L | Thursday, May 27, 2010 | ArticleLinks | 0 comments »________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.